Medicine & Life Sciences
Breast Neoplasms
100%
Aromatase Inhibitors
59%
Trastuzumab
40%
Neoplastic Stem Cells
27%
Neoplasms
24%
entinostat
18%
Therapeutics
15%
Estrogen Receptors
13%
Circulating Neoplastic Cells
13%
Letrozole
12%
Lapatinib
12%
human ERBB2 protein
12%
Biomarkers
11%
exemestane
11%
B 31
10%
Side-Population Cells
9%
Histone Deacetylase Inhibitors
9%
Survival
9%
Hormones
9%
Breast
9%
Vaccines
9%
Vaccination
8%
Aromatase
8%
Triple Negative Breast Neoplasms
8%
Drug Therapy
8%
Coronavirus
7%
pertuzumab
6%
taxane
6%
Mastectomy
6%
Acupuncture
6%
Macrophages
6%
Tumor Burden
5%
Immunity
5%
Population
5%
Randomized Controlled Trials
5%
Recurrence
5%